For the current REF see the REF 2021 website REF 2021 logo

Staff members (REF1a/c)

1 - Clinical Medicine

University of Edinburgh

1 2 3 4 5
Showing staff members 51 - 100 of 231
Name
Dhaun, N.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Diaz, M.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Dickinson, P.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Din, F.
Research group(s)
  • A - The Institute for Genetics & Molecular Medicine
Category
A
Name
Ditzel, M.
Research group(s)
  • A - The Institute for Genetics & Molecular Medicine
Category
A
Name
Dixon, M.
Research group(s)
  • A - The Institute for Genetics & Molecular Medicine
Category
C
Category C explanatory text

Profile:

Professor Mike Dixon, OBE, is Consultant Breast Surgeon and Professor of Breast Surgery, NHS Lothian Breast Unit, Western General Hospital, Edinburgh. He has had a long-standing research programme into mechanisms of endocrine resistance in breast cancer, both early and late. He was clinical director of Edinburgh Breakthrough Breast Cancer Unit 2008-2013, and retains grant income from Breakthrough Breast Cancer.

Research and links to the UoA:

He has conducted a series of clinical intervention trials in early breast cancer, and pioneered the pre-operative ”window” trial to explore effect of systemic drug therapy on operable breast cancer. He collaborates with University of Edinburgh scientists Simms, Brunton and Gilbert in the Institute for Genetics & Molecular Medicine (IGMM) and Clinical Surgery. He also has strong research links with the Institute of Cancer Research and George Washington University, USA.

Examplar publications:

- Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer, Breast Cancer Res Treat. 2010 Jul;122(2):419-28;

- Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole

J Clin Oncol. 2009 Mar 20;27(9):1382-7.

He has undertaken REF2014-period University of Edinburgh PhD student supervision (Aljarrah, Macaskill, McCaig).

Further information:

http://www.ed.ac.uk/schools-departments/surgery/staff/surgical-profiles/michael-dixon

Name
Dorin, J.
Research group(s)
  • A - The Institute for Genetics & Molecular Medicine
Category
A
Name
Drake, A.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Dransfield, I.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Duncan, C.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Dunlop, M.
Research group(s)
  • A - The Institute for Genetics & Molecular Medicine
Category
A
Name
Dweck, M.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Dzierzak, E.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Eddleston, M.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Evans, K.
Research group(s)
  • A - The Institute for Genetics & Molecular Medicine
Category
A
Name
Evans, M.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Farrington, S.
Research group(s)
  • A - The Institute for Genetics & Molecular Medicine
Category
A
Name
Feng, Y.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Finch, A.
Research group(s)
  • A - The Institute for Genetics & Molecular Medicine
Category
A
Name
Fischbacher, C.
Research group(s)
  • A - The Institute for Genetics & Molecular Medicine
Category
C
Category C explanatory text

Profile:

Dr Colin Fischbacher is a Consultant in Public Health Medicine at the Information and Statistics Division of the NHS in Scotland.

Research and links to the UoA:

Fischbacher has published research on a range of topics in epidemiology and is a member of Scottish research networks. He has a particular interest in policy implications of research and has published two important articles in the New England Journal of Medicine on the impact of the recent smoking legislation in Scotland:

- Smoke-free Legislation and Hospitalizations for Acute Coronary Syndrome, N Engl J Med 2008; 359:482-491 July 31, 2008DOI: 10.1056/NEJMsa0706740

- Smoke-free Legislation and Hospitalizations for Childhood Asthma

N Engl J Med 2010; 363:1139-1145September 16, 2010DOI: 10.1056/NEJMoa1002861.

He is a member of University of Edinburgh Centre for Population Health Sciences. He has worked collaboratively on several research projects with Professors Campbell, Wild and Bhopal. He has published widely in high impact journals, including 13 papers with Wild and 10 with Bhopal in the REF2014 period, and is established within the Centre for Public Health Sciences. He holds a research grant as a PI to estimate the burden of disease in Scotland.

Further information:

http://www.cphs.mvm.ed.ac.uk/people/staffProfile.php?profile=cfischba

Name
FitzPatrick, D.
Research group(s)
  • A - The Institute for Genetics & Molecular Medicine
Category
A
Name
Flatman, P.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Forbes, S.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Forbes, S.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Forrester, L.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Fox, K.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Frame, M.
Research group(s)
  • A - The Institute for Genetics & Molecular Medicine
Category
A
Name
Gammoh, N.
Research group(s)
  • A - The Institute for Genetics & Molecular Medicine
Category
A
Name
Garden, J.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Ghazal, P.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Gilbert, N.
Research group(s)
  • A - The Institute for Genetics & Molecular Medicine
Category
A
Name
Glasier, A.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
C
Category C explanatory text

Profile:

Professor Anna Glasier, OBE, is considered the world expert in emergency contraception (EC). Glasier's work in developing new methods of EC, exploring ways to increase EC use and evidence provision has allowed countries to make EC available off-prescription.

Research and links to the UoA:

Glasier's data led to UK Government approval of alternative emergency contraception available over the counter (OTC) in 2001. The Scottish Government made EC available OTC for this purpose for free, from 2008, resulting in a 10% drop in abortion rates in Scotland, 2008-2012.

A subsequent multi-centre randomised trial and meta-analysis of 2,221 women, led by Glasier and Cameron (NHS colleague and UoE Hon. Senior Lecturer), showed that ulipristal acetate is the safest, best form of emergency contraception. References:

1. Glasier AF, Cameron ST, Fine PM et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet 2010; 375:555-62.

2. Warner P, Guttinger A, Glasier AF, Lee RJ, Nickerson S, Brenner RM, Critchley HO. Randomized placebo-controlled trial of CDB-2914 in new users of a levonorgestrel-releasing intrauterine system shows only short-lived amelioration of unscheduled bleeding. Hum Reprod. 2010;25(2):345-53.

She maintains strong research links with Professor Critchley in MRC Centre for Reproductive Health.

Name
Gourley, C.
Research group(s)
  • A - The Institute for Genetics & Molecular Medicine
Category
A
Name
Gray, A.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
C
Category C explanatory text

Profile:

Professor Alasdair Gray is Consultant in Emergency Medicine, Royal Infirmary of Edinburgh, College Professor of Emergency Medicine and Honorary Reader, University of Edinburgh.

Research and links to the UoA:

Professor Gray is lead local investigator for numerous clinical trials addressing cardiovascular outcomes in emergency medicine.

He is co-applicant for several major grants, including two HTA grants (supporting the RATPAC and 3MG Trials) and one CSO programme (the SNAP Trial). He has more than 30 publications in the REF2014 period, notably collaborating with Newby et al in the BHF-University of Edinburgh Centre for Cardiovascular Science to investigate cardiogenic pulmonary oedema (NEJM 2008, Circ Heart Fail 2010) and syncope (JACC 2010) and with Eddleston and Webb in studies of poisoning (Lancet 2013).

He is formally an Affiliate Member of BHF-UoE Centre for Cardiovascular Science, where he holds an Honorary Readership and shares grants with Newby. He is a co-author with Newby, Eddleston, Webb and others.

Further information:

http://www.nhslothian.scot.nhs.uk/Services/A-Z/EMeRGE/ContactUs/Pages/AlasdairGray.aspx

Name
Gray, G.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Gray, M.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Gray, N.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Gray, R.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Gregory, C.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Hadoke, P.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Harris, S.
Research group(s)
  • A - The Institute for Genetics & Molecular Medicine
Category
A
Name
Haslett, C.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Hastie, N.
Research group(s)
  • A - The Institute for Genetics & Molecular Medicine
Category
A
Name
Hay, D.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Hayes, P.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Hayward, C.
Research group(s)
  • A - The Institute for Genetics & Molecular Medicine
Category
A
Name
Heck, M.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Henderson, N.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
A
Name
Hill, A.
Research group(s)
  • B - The Queen's Medical Research Institute
Category
C
Category C explanatory text

Profile:

Dr Adam Hill is Consultant Respiratory Physician, Royal Infirmary of Edinburgh (RIE), Training Programme Director for South-East of Scotland, Scottish Lead for Respiratory Medicine.and Honorary Reader, MRC Centre for Inflammation Research (MRC-CIR), University of Edinburgh. He is a leading expert on Bronchiectasis and is greatly involved in the work of the British Thoracic Society.

Research and links to the UoA:

His activities link research programmes based in the Respiratory Medicine Unit, RIE, and respiratory research activity in the MRC-CIR and the Centre for Cardiovascular Sciences (CVS).

He has three current research studies:

i) Deficiency in lipoxin (LXA4) contributes to persistent neutrophilic airways inflammation in non-cystic fibrosis bronchiectasi - a CSO fellowship supporting Pallavi Mandal, co-supervised by Rossi and Davidson, based in MRC-CIR.

ii) a Chest, Heart and Stroke Scotland-funded study 'Can bacterial load define chest infections in bronchiectasis?' supporting clinical fellow, Manjit Sidhu, co-supervised by Rossi, MRC-CIR.

iii) MIMIC, Multifunctional Integrated Microsystem for rapid point-of-care TB IdentifiCation, funded by the Technology Strategy Board, to develop a TB diagnostic test.

He has strong research links with Haslett, Rossi and Davidson in CIR and Newby in CVS and has multiple co-authored publications with members of these two Centres.

Further information:

http://www.research.ed.ac.uk/portal/en/persons/adam-hill(196f49cc-f734-4ddf-82c4-221caee875f7).html

Name
Hill, B.
Research group(s)
  • A - The Institute for Genetics & Molecular Medicine
Category
A
1 2 3 4 5
Showing staff members 51 - 100 of 231